Filing Flows › Firefly Neuroscience (AIFF) › Q1 2026 › vs Q1 2025
Firefly Neuroscience (AIFF) Q1 2026 vs Q1 2025 (year over year)
Firefly Neuroscience's revenue rose $442K (11×) from $43K in Q1 2025 to $485K in Q1 2026. The biggest changes: Service +$207K (24×); Subscription and Circulation +$161K (—); Product +$87K (—).
Firefly Neuroscience, Q1 2026: revenue $485K (11× year over year), operating margin -414.4%, net loss $2.0M, operating cash flow −$1.9M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Service | $216K | $9K | $207K | 24× |
| Subscription and Circulation | $161K | $0 | $161K | — |
| Product | $87K | $0 | $87K | — |
| Rentals | $15K | $34K | −$19K | -56% |
| Product and Service, Other | $6K | $0 | $6K | — |
| Revenue | $485K | $43K | $442K | 11× |
| Other income, net | $6K | −$10.9M | $10.9M | — |
| Net loss | $2.0M | $12.9M | −$10.9M | -85% |
| Costs & expenses | $2.5M | $13.0M | −$10.5M | -81% |
| Operating costs | $2.5M | $2.1M | $387K | +18% |
| Cost of revenue | $264K | $0 | $264K | — |
| Research & development | $424K | $312K | $112K | +36% |
| Sales & marketing | $141K | $208K | −$67K | -32% |
| General & admin | $1.7M | $1.6M | $78K | +5% |
| Operating cash sources | $2.4M | $2.8M | −$361K | -13% |
| Depreciation & amortization | $45K | $19K | $26K | +137% |
| Share-based compensation | $423K | $247K | $176K | +71% |
| Cash used in operations | $1.9M | $2.5M | −$563K | -22% |
| Net loss absorbed | $2.0M | $12.9M | −$10.9M | -85% |
| Working capital & other | $412K | −$10.2M | $10.6M | — |
Questions
How much did Firefly Neuroscience's revenue grow year over year in Q1 2026?
Firefly Neuroscience's revenue rose $442K (11×) from $43K in Q1 2025 to $485K in Q1 2026.
What drove Firefly Neuroscience's revenue change in Q1 2026?
Service +$207K (24×); Subscription and Circulation +$161K (—); Product +$87K (—).